Related Experiment Video
Updated: Mar 28, 2026

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Published on: November 26, 2018
Multi-Angle Effector Function Analysis of Human Monoclonal IgG Glycovariants
Tetyana Dashivets1,2, Marco Thomann3, Petra Rueger1
1Biochemical and Analytical Research, Large Molecule Research, Roche Pharma Research and Early Development (pRED), Roche Innovation Center, Penzberg, Germany.
Antibody glycosylation significantly impacts therapeutic antibody effector functions by influencing Fc receptor binding. Immune complex formation enhances Fc receptor-mediated functions, crucial for therapeutic efficacy.
Area of Science:
- Immunology
- Biochemistry
- Therapeutic Antibody Engineering
Background:
- Therapeutic antibody efficacy depends on antigen recognition and Fc-mediated effector functions.
- Fc receptor (FcR) interactions, particularly with Fc gamma receptors (FcγRs), are critical for antibody-dependent cellular cytotoxicity, complement-dependent cytotoxicity, and serum half-life.
- The Fc-linked glycan moiety is essential for IgG effector functionality, influencing FcγR affinity and binding to activating or inhibitory receptor classes.
Purpose of the Study:
- To systematically analyze the effector functions of monoclonal IgG1 and its eight engineered glycosylation variants.
- To investigate the impact of glycosylation on antibody stability and FcγR interactions, both for free antibodies and when bound to antigen or in immune complexes.
- To elucidate the role of glycosylation in IgG1 interaction with FcRn and the influence of immune complex formation on FcR-mediated functions.
Main Methods:
- Enzymatic engineering of monoclonal IgG1 to create eight distinct glycosylation variants.
- Systematic analysis of effector functions, including FcγR binding assays for single antibodies, antigen-bound antibodies, and immune complexes.
- Assessment of structural properties and antibody stability in relation to glycosylation patterns.
Main Results:
- Deglycosylated antibodies showed impaired binding to most FcγRs, except for FcγRI.
- Galactosylation levels directly influenced IgG1 binding to FcγRII and FcγRIIIa, with hypergalactosylated antibodies showing increased interaction.
- Sialylation of antibodies enhanced binding to FcγRIIa and FcγRIIb, and immune complex formation compensated for reduced FcR binding of target-bound antibodies.
Conclusions:
- Glycosylation patterns significantly impact IgG1 stability and FcγR interaction profiles.
- Specific glycan modifications, such as increased galactosylation and sialylation, can modulate FcγR binding and potentially enhance effector functions.
- Immune complex formation is critical for FcR-mediated effector functions, overcoming reduced affinity of target-bound antibodies.
More Related Videos
10:50Purification and Analytics of a Monoclonal Antibody from Chinese Hamster Ovary Cells Using an Automated Microbioreactor System
Published on: May 1, 2019
11:10Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study
Published on: June 29, 2016